View Older Stories View More Recent Stories
-
TD Cowen Reiterates Buy Rating on CVS Health (CVS); 'MA Final Rate Notice Positive'
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
BofA Securities Reiterates Buy Rating on CVS Health (CVS)
-
Leerink Partners Reiterates Outperform Rating on CVS Health (CVS)
-
CVS Health (CVS) Appoints Brian Newman as CFO, Amy Compton-Phillips as Chief Medical Officer
-
After-hours movers: Broadcom, Levi, Human and more
-
Trump Administration Medicare Insurer Rate Increase Doubles Prior Proposal -- WSJ
-
BofA: 'Weekly GLP-1 TRx growth in March is trending slightly ahead of February'
-
Given contract opportunity Caid stocks likely undervalued, says Cantor Fitzgerald
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 3.9% Yield
-
BofA Positive on UnitedHealth Group (UNH) and CVS (CVS) Reserves Positions, Negative on Humana (HUM)
-
Bernstein on Value Based Care Sector: 'We See an Attractive Set Up'
-
CVS Health (CVS) PT Raised to $70 at Mizuho
-
Wellvana acquires CVS Health's (CVS) MSSP business
-
CVS Health (CVS) enhances flu testing and treatment, offers at-home testing
-
Humana (HUM) Trades Lower in Sympathy with UnitedHealth Group (UNH)
-
CVS Health (CVS) PT Raised to $71 at Bernstein on 'Greater Confidence in Jump Off Point in Aetna Earnings'
-
Thermo Fisher Scientific (TMO) Appoints Karen S. Lynch to its Board
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
CVS Health (CVS) PT Raised to $75 at Raymond James
-
CVS Health (CVS) PT Raised to $76 at Truist Securities
-
CVS Health (CVS) PT Raised to $75 at BofA Securities
-
Leerink Partners Upgrades CVS Health (CVS) to Outperform
-
Popular stocks with increasing volume: SMCI INTC PLTR BABA HOOD LYFT UBER MSTR CVS
-
CVS Health (CVS) Tops Q4 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance
-
CVS Health earnings preview: Analysts eye 2025 guidance and medicare advantage turnaround
-
CVS Health (CVS) PT Lowered to $59 at UBS
-
Edward Jones Upgrades CVS Health (CVS) to Buy
-
CVS Health (CVS) call put ratio 6.8 calls to 1 put as Trump administration pauses assistance program payouts
-
CVS Health (CVS) PT Raised to $55 at Leerink Partners
-
CVS Health (CVS) PT Raised to $65 at Evercore ISI
-
Piper Sandler Highlights CVS Health (CVS) as Top Pick, Reiterates OW
-
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
-
Humana (HUM), Others Gain After Proposal Could Lead to Increased Payments from MA Plans
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 6% Yield
-
House Republicans Are Eyeing A Package To Extend Govt Funding For Three Months - Punchbowl
-
CVS Health (CVS) PT Lowered to $51 at Baird
-
CVS Health (CVS) Prices Maximum Tender Offer
-
Trump on drug industry: We're going to knock out the middle man
-
CVS Health (CVS) call put ratio 1.3 calls to 1 put with focus on February 65 calls as share price down 5%
-
Bipartisan Legislation To Be Introduced to Force Health Insurers to Give Up Pharmacy Businesses -- WSJ
-
CVS Health (CVS) call put ratio 3.4 calls to 1 put with focus on December 13 weekly 57 calls
-
CVS Health (CVS) Looks At Selling Bonds While Offering to Buy Back Debt: Bloomberg
-
CVS Health (CVS) PT Raised to $80 at TD Cowen
-
CVS Health (CVS) PT Lowered to $64 at Piper Sandler
-
CVS Health (CVS) Appoints Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman to its Board
-
CVS Health (CVS) PT Lowered to $57 at Leerink Partners
-
Trump picks RFK Jr for HHS — Here are potential policy implications
-
CVS Health (CVS) PT Lowered to $58 at RBC Capital
-
CVS Health (CVS) Appoints Steve Nelson as President, Aetna
